Found 11 articles for: "Dupilumab"

Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab

December 2023 | Volume 22 | Issue 12 | Case Reports | 1220 | Copyright © December 2023

Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab

July 2023 | Volume 22 | Issue 7 | Case Reports | 685 | Copyright © July 2023

Dupilumab Induced Hair Regrowth in Alopecia Totalis

April 2023 | Volume 22 | Issue 4 | Case Reports | 410 | Copyright © April 2023

A Qualitative Study on Dupilumab's Impact on Atopic Dermatitis Among Adolescent and Adult Patients

February 2023 | Volume 22 | Issue 2 | Original Article | 148 | Copyright © February 2023

Background: Atopic dermatitis (AD) is the most common inflammatory skin disease and dupilumab is US Food and Drug Administration-approved in both adult and pediatric AD patients.
Read More

The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review

October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022

Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read More

Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019

October 2022 | Volume 21 | Issue 10 | Editorials | 1138 | Copyright © October 2022

Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, ho...
Read More

Pustular Psoriasis Appearing Induced by Dupilumab Therapy in a Patient With Atopic Dermatitis

March 2022 | Volume 21 | Issue 3 | Case Reports | 311 | Copyright © March 2022

Dupilumab inhibits T-helper 2 (Th2)-driven inflammation cascade by blocking interleukin-4 (IL-4) and IL-13 signaling, which has been recognized to play a crucial role in the pathogenesis of atopic der...
Read More

Analysis of Reddit Reveals Dupilumab Questions Among Atopic Dermatitis Patients

March 2022 | Volume 21 | Issue 3 | Original Article | 292 | Copyright © March 2022

Background: Atopic dermatitis patients are turning to social media to seek guidance and source medical information. Reddit, the seventh most visited website in the US, contains the po...
Read More

Nonresponse and Progression of Diffuse Keloids to Dupilumab Therapy

February 2022 | Volume 21 | Issue 2 | Case Reports | 197 | Copyright © February 2022

Th2 cytokines, including IL-4 and IL-13, have been shown to increase TGFβ, promoting fibrosis. A recent study showed keloid improvement in one patient after administration of Dupilumab, an IL-4 r...
Read More

Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab

December 2021 | Volume 20 | Issue 12 | Case Reports | 1340 | Copyright © December 2021

Chromate causes persistent, difficult to treat irritant and allergic contact dermatitis in cement-handling occupational workers. When therapeutics such as topical corticosteroids, topical calcineurin ...
Read More

Successful Treatment of Brunsting-Perry Cicatricial Pemphigoid With Dupilumab

October 2021 | Volume 20 | Issue 10 | Case Reports | 1113 | Copyright © October 2021

Brunsting-Perry is a rare variant of cicatricial pemphigoid, characterized by subepidermal bullae localized to the head and neck. Currently, treatment relies on non-specific immunosuppression, which i...
Read More